| George Frederick Geils Sr, MD | |
|
125 Doughty St, Suite 280, Charleston, SC 29403 | |
| (843) 577-6957 | |
| (843) 577-6523 |
| Full Name | George Frederick Geils Sr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 125 Doughty St, Charleston, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285692855 | NPI | - | NPPES |
| P00360040 | Other | SC | RAILROAD MEDICARE |
| O52043 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 5204 (South Carolina) | Primary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 05204 (South Carolina) | Secondary |
| Entity Name | Charleston Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427140425 PECOS PAC ID: 3173521002 Enrollment ID: O20061201000038 |
News Archive
In the US, drug and alcohol testing has been a part of addiction and recovery for as long as I can remember. I started working in the business, basically in the employment industry, back in the mid-to-late 90s. Testing was essential, in that industries needed to ensure they had alcohol- and drug-free work places
About 54,000 people in Ethiopia living with or affected by HIV/AIDS will receive nutritional assistance from the U.N. World Food Programme under a new agreement announced Tuesday, the Daily Monitor/AllAfrica.com reports.
Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin Smart Catheter technology portfolio.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
Over the last 25 years, intensive efforts by physicians, physical therapists, and occupational therapists have developed integrative rehabilitation regimens that can alleviate balance disorders associated with neurological disease, trauma or weightlessness.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George Frederick Geils Sr, MD 125 Doughty St, Suite 280, Charleston, SC 29403 Ph: (843) 577-6957 | George Frederick Geils Sr, MD 125 Doughty St, Suite 280, Charleston, SC 29403 Ph: (843) 577-6957 |
News Archive
In the US, drug and alcohol testing has been a part of addiction and recovery for as long as I can remember. I started working in the business, basically in the employment industry, back in the mid-to-late 90s. Testing was essential, in that industries needed to ensure they had alcohol- and drug-free work places
About 54,000 people in Ethiopia living with or affected by HIV/AIDS will receive nutritional assistance from the U.N. World Food Programme under a new agreement announced Tuesday, the Daily Monitor/AllAfrica.com reports.
Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin Smart Catheter technology portfolio.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
Over the last 25 years, intensive efforts by physicians, physical therapists, and occupational therapists have developed integrative rehabilitation regimens that can alleviate balance disorders associated with neurological disease, trauma or weightlessness.
› Verified 2 days ago
Dr. Jeffrey Peter Yourshaw, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-876-4807 Fax: 843-876-4809 | |
Jennifer Lee Martin, D.O. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Nikko Rowe Asuncion Tabliago, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 | |
Moses K Asempah, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 717-491-3745 | |
Paige Nicole Laverick, PA-C Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Amit Agrawal, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Yevgeniy Gelfand, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-0111 |